Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03163225 · ClinicalTrials.gov registry record
Opportunities in Outpatient Care
A clinical trial, sponsored by Intermountain Health Care.
- Completed
- Registry status
- 1,027
- Enrollment target
NCT03163225: Completed study, sponsored by Intermountain Health Care.
NCT03163225 is a clinical trial that has completed, run by Intermountain Health Care. The registered enrollment target is 1,027 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03163225 has completed, sponsored by Intermountain Health Care.
- COMPLETED
- Registry status
- 1,027 participants
- Enrollment target
Study Summary
The purpose of this research study is to determine whether there are things that Intermountain can do to break down barriers to helping patients see their primary doctors or other outpatient clinics. To do this we will develop and test a classification scheme to help us understand how we might reduce some avoidable emergency department and InstaCare visits.
Primary Outcome
The proportion of ED visits during the selected shifts that were deemed to be potentially avoidable according to the developed taxonomy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,027 participants |
| Start Date | 2017-09-01 |
| Est. Completion | 2017-10-31 |
What the finished NCT03163225 record still lists
NCT03163225 is an observational study that tracks outcomes without assigning an intervention. Its 1,027 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT03163225 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03163225 about?
NCT03163225 is a clinical study titled "Opportunities in Outpatient Care". The purpose of this research study is to determine whether there are things that Intermountain can do to break down barriers to helping patients see their primary doctors or other outpatient clinics. To do this we will develop and test a classification scheme to help us understand how we might reduc...
What is the current status of trial NCT03163225?
This trial is currently completed. The enrollment target is 1,027 participants. The study started on 2017-09-01. Estimated completion is 2017-10-31.
Who is sponsoring clinical trial NCT03163225?
This trial is sponsored by Intermountain Health Care, which has 85 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02200276 · 1,025 participants · NA
Influenza Immunization in Adults Over Age 75
- NCT02296450 · 1,025 participants
Quality of Life (QoL) Assessment in Cancer Patients and Survivors With Dermatologic Conditions Using Dermatologic QoL Instruments
- NCT06080698 · 1,030 participants · NA
Gram-Negative Bloodstream Infection Oral Antibiotic Therapy Trial
- NCT06888011 · 1,024 participants · NA
iAmHealthy Clinical Practice Guideline (CPG)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI